<DOC>
	<DOCNO>NCT00123565</DOCNO>
	<brief_summary>The purpose study test whether SR123781A possible treatment patient acute coronary syndrome ( heart attack ) schedule undergo percutaneous coronary intervention ( PCI ) within 48 hour inclusion study . Two dos SR123781A currently test , group 180 patient per group find adequate , versus heparin glycoprotein IIbIIIa ( GPIIBIIIA ) antagonist .</brief_summary>
	<brief_title>Hexadecasaccharide ( SR123781A ) Patients With Unstable Angina Non-ST-Segment Elevation Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>A person diagnosis acute coronary syndrome schedule undergo PCI within 48 hour . A person legal age 21 , mentally competent , sign write informed consent A person know allergy contraindication active control . A person receive heparin 48 hour inclusion study . A person treat warfarin ( oral anticoagulant ) . A person current bleeding recognize increase risk bleed history intracranial hemorrhage . A person stroke within last 6 month . A person uncontrolled hypertension despite antihypertensive therapy . A person history clinically significant reduction blood platelet neutrophil ( white blood cell ) . A person laboratory evidence significantly reduce renal function dependent renal dialysis . A person coronary bypass perform previous month . A pregnant nursing woman woman childbearing potential ( menopause ) negative pregnancy test use reliable method birth control . A person receive investigational treatment precede month .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Coronary Disease</keyword>
</DOC>